Anu (Vaidyanathan) Connor is an accomplished professional in the field of oncology and biomedical research, currently serving as Vice President and Head of Oncology External Innovation at Ipsen. Prior experience includes a role as Senior Director for Hematology & Oncology Search and Evaluation in Business Development at Bristol Myers Squibb, and Global Head of Due Diligence, Search and Evaluation in Business Development and Licensing at Novartis Institutes for BioMedical Research. Anu has also held positions such as Director of Toxicology at Stemcentrx, Inc., and Pharmacology Subteam Leader & Scientist at Genentech. Academic credentials include a PhD in Biomedical Sciences from Northeastern University and a BS in Biology with a minor in Microbiology from the University of Massachusetts Amherst.